Open access · CC-BY
via OpenAlex
Senotherapeutic drugs for human intervertebral disc degeneration and low back pain
Hosni Cherif, Daniel G. Bisson, Matthew Mannarino, Oded Rabau, Jean Albert Ouellet, Lisbet Haglund
eLife · 2020 · ▲ 121 citations
Abstract
Cellular senescence(definition) is a contributor to intervertebral disc (IVD) degeneration and low back pain. Here, we found that RG-7112, a potent mouse double-minute two protein inhibitor, selectively kills senescent IVD cells through apoptosis. Gene expression pathway analysis was used to compare the functional networks of genes affected by RG-7112, a pure synthetic senolytic with o-Vanillin a natural and anti-inflammatory senolytic. Both affected a functional gene network related to cell death and survival. O-Vanillin also affected networks related to cell cycle progression as well as connective tissue development and function. Both senolytics(definition) effectively decreased the senescence-associated secretory phenotype (SASP) of IVD cells. Furthermore, bioavailability and efficacy were verified ex vivo in the physiological environment of degenerating intact human discs where a single dose improved disc matrix homeostasis. Matrix improvement correlated with a reduction in senescent cells and SASP, supporting a translational potential of targeting senescent cells as a therapeutic intervention.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.7554/elife.54693
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Cherif, H., Bisson, D.G., Mannarino, M., Rabau, O., Ouellet, J.A., & Haglund, L. (2020). Senotherapeutic drugs for human intervertebral disc degeneration and low back pain. <em>eLife</em>. https://doi.org/10.7554/elife.54693
Vancouver
Cherif H, Bisson DG, Mannarino M, Rabau O, Ouellet JA, Haglund L. Senotherapeutic drugs for human intervertebral disc degeneration and low back pain. eLife. 2020. doi:10.7554/elife.54693.
BibTeX
@article{hosni2020Senoth,
title = {Senotherapeutic drugs for human intervertebral disc degeneration and low back pain},
author = {Hosni Cherif and Daniel G. Bisson and Matthew Mannarino and Oded Rabau and Jean Albert Ouellet and Lisbet Haglund},
journal = {eLife},
year = {2020},
doi = {10.7554/elife.54693},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2020
Open access · CC-BY
Author response: Senotherapeutic drugs for human intervertebral disc degeneration and low back pain
Biomolecules 2023
Open access · CC-BY
Senolytic Combination Treatment Is More Potent Than Single Drugs in Reducing Inflammatory and Senescence Burden in Cells from Painful Degenerating IVDs
Journal of Orthopaedic Translation 2024
Open access · CC-BY
Mechanisms and therapeutic strategies for senescence-associated secretory phenotype in the intervertebral disc degeneration microenvironment
Arthritis Research & Therapy 2007
Open access · CC-BY
Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration
European Respiratory Journal 2017
Open access · CC-BY
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Acta Pharmaceutica Sinica B 2025
Open access · CC-BY